Effect of Alpha-Lipoic Acid on Atrial Fibrillation after Open Heart Surgery
The Egyptian Cardiothoracic Surgeon · 2020
DOI: 10.35810/ects.v1i1.127 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian Cardiothoracic Surgeon, 2020. Verfasst von Wael Elfeky und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Postoperative atrial fibrillation (POAF) is associated with increased morbidity and mortality, and an inflammatory process is involved in its pathogenesis. We aimed to study the possible effect of alpha-lipoic acid (ALA) as an antioxidant on atrial fibrillation after cardiac surgery.
Methods
The study included ninety patients who underwent cardiac surgery, either valvular or coronary artery bypass grafting using cardiopulmonary bypass, and were randomized into two groups: Control and ALA groups. Blood samples were obtained to measure preoperative and postoperative levels of malondialdehyde (MDA), glutathione, C-reactive protein (CRP) and interleukin-6 (IL-6). The patients were monitored for the occurrence of atrial fibrillation until the day of discharge.
Results
POAF occurred in 33% in the control group versus 11% in the ALA group (p=0.011). When compared to the control group, ALA significantly decreased the postoperative levels of MDA (4.78±0.91 vs. 5.36±1.03 nmol/ml; p= 0.006) CRP (19.44±3.14 vs. 26.56±6.29 mg/dl; p
Zitieren
APA
Elfeky, W., & El-Afify, D. R. (2020). Effect of Alpha-Lipoic Acid on Atrial Fibrillation after Open Heart Surgery. The Egyptian Cardiothoracic Surgeon. https://doi.org/10.35810/ects.v1i1.127
Vancouver
Elfeky W, El-Afify DR. Effect of Alpha-Lipoic Acid on Atrial Fibrillation after Open Heart Surgery. The Egyptian Cardiothoracic Surgeon. 2020. doi:10.35810/ects.v1i1.127
BibTeX
@article{Elfeky2020,
author = {Elfeky, Wael and El-Afify, Dalia R},
title = {Effect of Alpha-Lipoic Acid on Atrial Fibrillation after Open Heart Surgery},
journal = {The Egyptian Cardiothoracic Surgeon},
year = {2020},
doi = {10.35810/ects.v1i1.127}
}
EUVIMED